Skip to main content
Caplight Logo









Catalera BioSolutions

Catalera BioSolutions

Private
VancouverHealthcare & Life Scienceshttps://www.catalera.com/

Last Round

Series A

Sep 10, 2024

Company Overview

Catalera BioSolutions is a biotechnology company that develops and commercializes biological solutions for pest control in plant, home, and public health sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

biopesticidebiological pesticidesbioactive deliveryagtechmicroparticle encapsulationbiological inputssustainable agriculturepest controlbiotechformulation technologybiologicalscrop protectionbio-based pesticidesspecialty crops

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Catalera BioSolutions Comparables

Compare Catalera BioSolutions with similar companies based on industry and business-model similarity.

Catalera BioSolutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Terramera
81%
Ascribe Bio
78%
BioCloak
76%

Catalera BioSolutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 10, 2024

Key People

Founding team and executive leadership

David Hollinrake

Chief Executive Officer

Executive Team

Matthew Dahabieh

CEO and Board Member

Executive Team

Catalera BioSolutions Investors

Notable investors and investment history

Catalera BioSolutions investors
InvestorRounds
Farm Credit Canada (FCC) CapitalSeries A
S2G InvestmentsSeries A

Catalera BioSolutions Filings

Explore SEC and related filing metadata, where available.

Catalera BioSolutions filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Catalera BioSolutions's valuation, stock price, and market status.

Is Catalera BioSolutions a public or private company?

Catalera BioSolutions is a private company.

What is the current stock price of Catalera BioSolutions?

Catalera BioSolutions is a private company with no public stock price. No recent secondary market data is available.

How much is Catalera BioSolutions worth (valuation)?

Valuation information for Catalera BioSolutions is not publicly available.

Can I buy Catalera BioSolutions stock?

Catalera BioSolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Catalera BioSolutions's last funding round?

Catalera BioSolutions's most recent funding round was Series A on September 10, 2024.

Who are the main investors in Catalera BioSolutions?

Key investors in Catalera BioSolutions include S2G Investments.

Will Catalera BioSolutions IPO soon?

No public IPO plans have been announced for Catalera BioSolutions.

How can I track Catalera BioSolutions secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Catalera BioSolutions's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVancouver
Employee Range24
Year Founded2024
Last FundingSep 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?